Perioperative Management of Pediatric Epilepsy Neuromodulation Devices

Area of Science:

• Pediatric Neurology
• Neurosurgery
• Biomedical Engineering

Background:

• Drug-resistant epilepsy (DRE) significantly impacts children and families, often limiting surgical options.
• Neuromodulation therapies provide palliative seizure management for DRE.
• Vagus nerve stimulation (VNS) is FDA-approved for pediatric epilepsy; deep brain stimulation (DBS) and responsive neurostimulation (RNS) are used off-label.

Purpose of the Study:

• To review neuromodulation therapies for pediatric DRE.
• To outline perioperative considerations for device implantation and management.
• To highlight safety and efficacy data for these devices in children.

Main Methods:

• Literature review of VNS, DBS, and RNS in pediatric epilepsy.
• Analysis of perioperative management strategies.
• Evaluation of current safety and efficacy data.

Main Results:

• Neuromodulation devices are effective palliative treatments for pediatric DRE.
• Perioperative care requires attention to device integrity and physiological changes.
• Current data suggest good efficacy and safety, with a need for long-term studies.

Conclusions:

• Neuromodulation offers a viable treatment option for pediatric DRE.
• Meticulous perioperative management is crucial for device longevity and patient safety.
• Continued education for healthcare providers is essential as device use increases.